Adiponectin and cardiovascular disease: state of the art?
about
Adiponectin as a potential biomarker of vascular diseasePharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients.Obesity and inflammation: the linking mechanism and the complicationsAdiponectin isoforms in elderly patients with or without coronary artery disease.Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages.Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study.Effects of simvastatin treatment on serum adiponectin concentrations in patients with dislipidemiaExercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity.Endothelial dysfunction in insulin resistance and type 2 diabetes.Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population.Association of adiponectin with type 2 diabetes and hypertension in African American men and women: the Jackson Heart Study.Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in womenAdiponectin: an adipokine with protective features against metabolic syndrome.Adiponectin and carotid intima-media thickness in the northern Manhattan study.Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy menAssociations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA).Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening.The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients.The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.The usefulness of circulating adipokine levels for the assessment of obesity-related health problemsVariants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study.Assessment of adiponectin level in obese and lean Nepalese population and its possible correlation with lipid profile: A cross-sectional study.The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?Associations of adiponectin and leptin with incident coronary heart disease and ischemic stroke in african americans: the jackson heart study.Reduced peripheral arterial blood flow with preserved cardiac output during submaximal bicycle exercise in elderly heart failure.Adiponectin gene polymorphisms and susceptibility to atherosclerosis: A meta-analysisPilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications.Relationship between Regional Body Fat Distribution and Diabetes Mellitus: 2008 to 2010 Korean National Health and Nutrition Examination Surveys.Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.The role of adiponectin in endothelial dysfunction and hypertension.Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass.Interventions to increase adiponectin may be associated with increased coronary heart disease in older adults.Adiponectin is related with carotid artery intima-media thickness and brachial flow-mediated dilatation in young adults--the Cardiovascular Risk in Young Finns Study.Adiponectin, cardiovascular disease, and mortality: parsing the dual prognostic implications of a complex adipokine.Leptin/adiponectin ratio in overweight patients - gender differences.Elevated levels of adipokines predict outcome after acute myocardial infarction: A long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.Association of Adiponectin With Cancer and All-Cause Mortality in a Japanese Community-Dwelling Elderly Cohort: A Case-Cohort Study.
P2860
Q26821925-7CFEC10F-68DF-495C-BAC9-AE8E3F7137E4Q30366778-4547B643-C656-4EA4-B546-EC1646EFE380Q30461204-E8463D79-5A10-4373-A5F6-AA70FE89C2F4Q33622255-0DD4B30D-3F33-4761-8275-68158C1268E3Q33897331-B93CD92B-34D8-4409-98D1-B46A0ADDD834Q34110542-50B8428F-A3F4-4ED0-9FCE-DFF320DF4077Q34150591-54BC78CB-EC43-499A-A434-153BAF792933Q34195243-D036639A-8689-4028-A3EC-48EF08C3C526Q34461505-04267B3C-22DA-4459-99DC-85491597C8B8Q34501780-F8304964-A9CE-49FA-92E4-6B6CD91F2C89Q34655075-2C2A5C79-DAA6-4FC6-8BC8-FE3FD1EE7C2DQ35043839-B398FEDF-5DE9-41A4-B2A6-6E93B4539ED1Q35163379-B78D23EA-716E-444D-B918-1CAC5AA1145EQ35501308-4099C453-3F7D-43FE-BFA1-C1732582A684Q35763433-3B416BAB-DDC0-4261-9573-1AA33DC7056CQ35858742-03F8A708-4C1F-4713-B23F-C2ABA20444C3Q36413168-F14363D7-1269-447A-B9F7-6A859239762FQ36434235-12CF5950-D48C-4518-9996-AF3F07E71C76Q36521413-F0FF5D18-BB9D-41F3-B46C-91901A4AF450Q36635081-F7E09A68-C1A2-4460-885A-E56AECDE27D8Q36768458-B384A3C1-FF07-44D3-A389-DE5F19ECD12FQ36859053-708BB00F-04E6-4E85-9314-5E12EB3EEA21Q37146544-B5D7354C-8F22-439B-BCBC-7BCAA471CB36Q37314707-5EEFFA23-921E-4BDF-895B-59C44A7376C6Q37362674-8EB24903-D7DA-4DD7-B045-FB68312E6186Q37372502-9C11CE50-DC08-48A6-B663-BA4FF4EECCBDQ37463069-6284521A-5D94-4998-BDDB-04C923B60B56Q37498140-CAA0EA03-3CF9-4088-84C8-D75C8358ADF8Q37602891-CE4CC7B2-14EE-4A3A-B8D0-E55B9CD4403EQ37670105-6D86A6CF-81AD-4A6A-8E29-5B5492421101Q37859679-7F7F4F33-405A-4435-AA2F-0F0543849BD5Q38125624-1C68074D-A551-4BDE-BB5E-9EBBC2EF16FCQ38219891-E64312A6-D66E-4B09-908D-F544C7663FEAQ38353803-49739414-43F5-4B25-A617-6FB2CECC3C41Q39986957-7191629B-D975-4B29-B91D-1C71A494C58DQ42907837-F4D5016D-629C-4683-A6E0-F087C9EBCC08Q42908938-06AF4A79-4249-4D87-A1B2-8C211EF8E2E6Q50115729-71171A36-5144-4D31-899D-1116AAE7ED26Q50900534-6ABEABB7-B3FE-483F-91CF-8E6E923F9216Q52632736-1BD7C75E-9A8E-44D3-B470-35AF7757FDC5
P2860
Adiponectin and cardiovascular disease: state of the art?
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adiponectin and cardiovascular disease: state of the art?
@ast
Adiponectin and cardiovascular disease: state of the art?
@en
type
label
Adiponectin and cardiovascular disease: state of the art?
@ast
Adiponectin and cardiovascular disease: state of the art?
@en
prefLabel
Adiponectin and cardiovascular disease: state of the art?
@ast
Adiponectin and cardiovascular disease: state of the art?
@en
P2093
P2860
P1476
Adiponectin and cardiovascular disease: state of the art?
@en
P2093
Duncan J Stewart
Paul E Szmitko
Subodh Verma
P2860
P304
P356
10.1152/AJPHEART.01072.2006
P50
P577
2006-12-01T00:00:00Z